As of 2026-01-03, the Relative Valuation of Cardiff Oncology Inc (CRDF) is (17.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.81 USD, the upside of Cardiff Oncology Inc based on Relative Valuation is -705.5%.
The range of the Relative Valuation is (13.73) - (18.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.2x | 17.7x |
| Forward P/E multiples | 14.4x - 21.6x | 18.0x |
| Fair Price | (13.73) - (18.30) | (17.01) |
| Upside | -588.5% - -751.3% | -705.5% |
| Date | P/E |
| 2025-12-31 | -2.95 |
| 2025-12-30 | -3.01 |
| 2025-12-29 | -3.09 |
| 2025-12-26 | -3.33 |
| 2025-12-24 | -3.34 |
| 2025-12-23 | -3.05 |
| 2025-12-22 | -3.06 |
| 2025-12-19 | -2.70 |
| 2025-12-18 | -2.62 |
| 2025-12-17 | -2.53 |
| 2025-12-16 | -2.52 |
| 2025-12-15 | -2.53 |
| 2025-12-12 | -2.51 |
| 2025-12-11 | -2.60 |
| 2025-12-10 | -2.57 |
| 2025-12-09 | -2.53 |
| 2025-12-08 | -2.45 |
| 2025-12-05 | -2.21 |
| 2025-12-04 | -2.27 |
| 2025-12-03 | -2.23 |
| 2025-12-02 | -2.14 |
| 2025-12-01 | -2.28 |
| 2025-11-28 | -2.39 |
| 2025-11-26 | -2.45 |
| 2025-11-25 | -2.21 |
| 2025-11-24 | -2.18 |
| 2025-11-21 | -2.13 |
| 2025-11-20 | -2.06 |
| 2025-11-19 | -2.10 |
| 2025-11-18 | -2.14 |
| 2025-11-17 | -2.16 |
| 2025-11-14 | -2.23 |
| 2025-11-13 | -2.26 |
| 2025-11-12 | -2.35 |
| 2025-11-11 | -2.40 |
| 2025-11-10 | -2.34 |
| 2025-11-07 | -2.30 |
| 2025-11-06 | -2.36 |
| 2025-11-05 | -2.35 |
| 2025-11-04 | -2.33 |
| 2025-11-03 | -2.42 |
| 2025-10-31 | -2.47 |
| 2025-10-30 | -2.34 |
| 2025-10-29 | -2.35 |
| 2025-10-28 | -2.41 |
| 2025-10-27 | -2.40 |
| 2025-10-24 | -2.34 |
| 2025-10-23 | -2.32 |
| 2025-10-22 | -2.27 |
| 2025-10-21 | -2.34 |